Previous malignancy is an independent predictor of follow ‐up mortality after Percutaneous treatment of Mitral Valve regurgitation by means of MitraClip

ConclusionsPrevious neoplasm is a significant independent predictor of increased mortality after MVR with MitraClip. This association is even stronger than that of other cardiac and overall comorbidities and should be kept into consideration when referring patients for treatment.This article is protected by copyright. All rights reserved.

Source: Cardiovascular Therapeutics - December 18, 2016 Category: Cardiology Authors: Alper Öner, Hüseyin Ince, Liliya Paranskaya, Guido Schröder, Mohammad Sherif, Olga Thiele, Alla Neuhausen, Kische Stephan, Jasmin Ortak, Giuseppe D′Ancona Tags: Original Article Source Type: research